MENU
VRAX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Virax Biolabs Group (VRAX) Ownership - Who owns Virax Biolabs Group?

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction... Show more

Profile

Industry
N/A
Address
20 North Audley Street
Phone
+44 2077887414
Employees
11
Web
https://www.viraxbiolabs.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.24M
P/E Ratio
N/A
Total Cash
3.35M
Projected Growth
N/A
Total Debt
537.99K
Revenue
2.99K
Risk (Beta)
1.52
Dividend Yield
N/A
Total Cash/Share
4.20
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
View a ticker or compare two or three
VRAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
20 North Audley Street
Phone
+44 2077887414
Employees
11
Web
https://www.viraxbiolabs.com